Berruti, A <br/><br/>
Independent prognostic role of circulating chromogranin A in prostate cancer patients with hormone-refractory disease.  [electronic resource] 

 -  Endocrine-related cancer  Mar 2005 
 - 109-17 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1351-0088 
<br/><br/><label>Standard No.: </label>10.1677/erc.1.00876  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Albumins--metabolism<br/>Alkaline Phosphatase--blood<br/>Biomarkers, Tumor--blood<br/>Bone Neoplasms--blood<br/>Cell Differentiation<br/>Chromogranin A<br/>Chromogranins--blood<br/>Hemoglobins--metabolism<br/>Humans<br/>L-Lactate Dehydrogenase--blood<br/>Liver Neoplasms--blood<br/>Lung Neoplasms--blood<br/>Male<br/>Middle Aged<br/>Neoplasm Staging<br/>Neoplasms, Hormone-Dependent--blood<br/>Prognosis<br/>Prospective Studies<br/>Prostate-Specific Antigen--blood<br/>Prostatic Neoplasms--blood<br/>Survival Rate